By using this website you agree that we use cookies. You can find out more in the privacy policy.

Arizona Tribune - Ryan Confer, President and Chief Executive Officer of Genprex, Inc., to Present at Investor Summit Virtual on September 16, 2025

Arizona Tribune
×
NYSE - LSE
RYCEF -2.15% 14.88 $
JRI -0.31% 12.77 $
BCC -4.31% 79.2 $
CMSC 0.04% 22.84 $
CMSD -0.52% 23.08 $
RBGPF -0.84% 63.47 $
RIO -1.9% 96.65 $
NGG -1.85% 85.86 $
BCE -1.14% 23.235 $
VOD -0.88% 15.355 $
RELX -0.56% 35.81 $
AZN -1.15% 184.56 $
GSK -5.57% 51.595 $
BTI -1.89% 57.385 $
BP 0.44% 46.555 $
Ryan Confer, President and Chief Executive Officer of Genprex, Inc., to Present at Investor Summit Virtual on September 16, 2025
Ryan Confer, President and Chief Executive Officer of Genprex, Inc., to Present at Investor Summit Virtual on September 16, 2025

Ryan Confer, President and Chief Executive Officer of Genprex, Inc., to Present at Investor Summit Virtual on September 16, 2025

BOULEVARD 10.09.2025

AUSTIN, TX / ACCESS Newswire / September 10, 2025 / Genprex, Inc.'s President and Chief Executive Officer, Ryan Confer, will present at the Investor Summit Virtual on September 16, 2025, offering investors an inside look at the company's growth strategies and market opportunities.

Text size:

About Genprex, Inc.
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.

Event Details

  • Event: Q3 Investor Summit

  • Presentation Date & Time: September 16 | 2:00 PM ET

  • Location: Webcast Link

Conference Overview and Structure

The Investor Summit is an exclusive virtual event for investors specializing in small and microcap stocks. Attendees will:

  • Hear directly from company executives about key strategies and milestones

  • Learn from industry experts and thought leaders

  • Explore opportunities in the microcap market

This quarter's event emphasizes undervalued MicroCap companies with strong growth catalysts, providing investors with a unique platform for discovery and engagement.

Investor Registration:
Investors can register for free using the link below: https://investorsummitgroup.fillout.com/t/8CZGk3gSQbus

Sponsors:
ACCESS Newswire | PCG Advisory | QuoteMedia | AGP | MZ Group

Media Contact:
For more information, please visit https://investorsummitgroup.com/ or contact [email protected]

SOURCE: Genprex, Inc.



View the original press release on ACCESS Newswire

R.Garcia--AT

Featured

London police probe 'terror' incident after two Jewish men stabbed

London police probe 'terror' incident after two Jewish men stabbed
Rob Reiner autopsy report not ready, court hears

Rob Reiner autopsy report not ready, court hears
Two Jewish men stabbed in 'terrorist' attack in London

Two Jewish men stabbed in 'terrorist' attack in London
US Supreme Court curbs race-based voting maps in landmark ruling

US Supreme Court curbs race-based voting maps in landmark ruling